Article (Scientific journals)
Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux, Laurence; Gillet, Nicolas; Stamatopoulos, Basile et al.
2007In Experimental Hematology, 35 (10), p. 1527-37
Peer reviewed
 

Files


Full Text
Laurence VPA CLL.pdf
Publisher postprint (737.91 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Aged; Aged, 80 and over; Anticonvulsants/pharmacology; Apoptosis/drug effects/genetics; B-Lymphocytes/metabolism/pathology; CASP8 and FADD-Like Apoptosis Regulating Protein/genetics/metabolism; Caspase 8/genetics/metabolism; DNA Fragmentation/drug effects; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm/drug effects/genetics; Drug Screening Assays, Antitumor; Enzyme Inhibitors/pharmacology; Female; Gene Expression Regulation, Leukemic/drug effects/genetics; Histone Deacetylases/antagonists & inhibitors/genetics; Humans; Immunoglobulin Heavy Chains/genetics/metabolism; Immunoglobulin Variable Region/genetics/metabolism; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy/genetics/metabolism/pathology; Male; Middle Aged; Mutation; Neoplasm Proteins/genetics/metabolism; Phosphatidylserines/metabolism; Signal Transduction/drug effects/genetics; TNF-Related Apoptosis-Inducing Ligand/metabolism; Tumor Cells, Cultured; Valproic Acid/pharmacology/therapeutic use
Abstract :
[en] OBJECTIVE: Chronic lymphocytic leukemia (CLL) cells develop chemoresistance over time associated with defects in apoptosis pathway. Novel treatment strategies are required to overcome resistance of cells to commonly used agents. The effects of valproic acid (VPA), an antiepileptic drug with histone deacetylase inhibitory activity, on mononuclear cells isolated from 40 CLL patients were evaluated. METHODS: CLL cells were treated with increasing doses of VPA (0.5, 1, 2, and 5 mM). The mode of cytotoxic drug action was determined by annexin binding, DNA fragmentation, and caspase activation. RESULTS: Exposure of CLL cells to VPA resulted in dose-dependent cytotoxicity and apoptosis in the 40 CLL patients. VPA treatment induced apoptotic changes in CLL cells including phosphatidylserine externalization and DNA fragmentation. The mean apoptotic rates were similar between IgV(H) mutated and unmutated patients, the latter presenting a more aggressive clinical course. VPA induced apoptosis via the extrinsic pathway involving engagement of the caspase-8-dependent cascade. Although CLL cells are commonly resistant to death receptor-induced apoptosis, VPA significantly increased sensitivity of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and led to downregulation of c-FLIP (L) expression. VPA caused no potentialization of TRAIL-induced apoptosis on normal B cells. In addition, VPA overcame the prosurvival effects of bone marrow stromal cells. CONCLUSION: These findings point out that the combination of TRAIL and VPA, at clinically relevant concentration, may be valuable in the treatment of CLL.
Disciplines :
Hematology
Oncology
Author, co-author :
Lagneaux, Laurence
Gillet, Nicolas ;  Université de Liège - ULiège > Chimie et bio-industries > Biologie cell. et moléc.
Stamatopoulos, Basile
Delforge, Alain
Dejeneffe, Marielle
Massy, Martine
Meuleman, Nathalie
Kentos, Alain
Martiat, Philippe
Willems, Luc  ;  Université de Liège - ULiège > GIGA-Research
Bron, Dominique
Language :
English
Title :
Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Publication date :
2007
Journal title :
Experimental Hematology
ISSN :
0301-472X
eISSN :
1873-2399
Publisher :
Elsevier, Amsterdam, Netherlands
Volume :
35
Issue :
10
Pages :
1527-37
Peer reviewed :
Peer reviewed
Available on ORBi :
since 07 April 2009

Statistics


Number of views
96 (5 by ULiège)
Number of downloads
1 (0 by ULiège)

Scopus citations®
 
57
Scopus citations®
without self-citations
51
OpenCitations
 
51

Bibliography


Similar publications



Contact ORBi